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Abstract Mindfulness-Based Cognitive Therapy
(MBCT) is a promising intervention to prevent depressive
relapse. Yet beyond efficacy studies, little is known
regarding the mechanisms that could be modified through
MBCT. Objectives of the present study were twofold:
determine whether cognitive functioning was altered
among patients remitted from depression at admission in a
MBCT trial; and document possible changes during the
trial and follow-up. In a cross-sectional perspective, cog-
nitive functioning (autobiographical memory, shifting
capacities, dysfunctional attitudes, mindful attention
awareness and rumination habits) was first compared
between 36 patients remitted from depression, 20 acutely
depressed patients and 20 control participants. In a longi-
tudinal perspective, changes in the remitted sample were
explored during a MBCT plus Treatment As Usual versus
Treatment As Usual randomized controlled trial and
9-month follow-up. Performances of remitted patients were
similar to the ones of control participants for autobio-
graphical memories, shifting capacities, and mindful
attention awareness, whereas levels of rumination and
dysfunctional attitudes were significantly elevated. Partic-
ipation in the MBCT program was accompanied with a
significant decrease of dysfunctional attitudes that contin-
ued up to 9-month postintervention. No other change was
observed that was specific to MBCT. Results suggest that
MBCT might help people to identify dysfunctional atti-
tudes at a very early stage and to avoid engaging further in
these attitudes.
Keywords Mindfulness  Depression  Remission 
Cognitive functioning
Introduction
Ten years ago, Mindfulness-Based Cognitive Therapy
(MBCT; Segal et al. 2002a) was developed to prevent
depressive relapse. Since then, four randomized controlled
trials (RCT) have compared MBCT ? TAU (Treatment As
Usual) to TAU only (Bondolfi et al. 2010; Godfrin and van
Heeringen 2010; Ma and Teasdale 2004; Teasdale et al.
2000). A recent meta-analysis of these studies (Chiesa and
Serretti 2011) concluded that 32 % of patients with 3 or
more past depressive episodes relapsed in the 12 months
following MBCT compared to 60 % of patients with TAU
only. All four studies demonstrated that MBCT signifi-
cantly delayed relapse compared to TAU. Other studies
showed that MBCT leads to relapse/recurrence rates that
are comparable to those of patients with maintenance
antidepressant medication, suggesting that MBCT could be
an alternative to pharmacotherapy (Kuyken et al. 2008;
Segal et al. 2010).
Beyond the need to establish the efficacy of a new
treatment, the psychological and cognitive mechanisms
that may be modified by mindfulness treatments or account
for observed benefits require clarification (e. g. Bishop
et al. 2004; Grossman et al. 2004). Better identifying
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mechanisms of action could help to adapt existing inter-
ventions (e.g. increasing or decreasing the time allocated to
mindfulness practices). One of the known impacts of
Mindfulness-Based Therapies is their positive effect on
anxiety and depressive symptomatology (see Hofmann
et al. 2010 for a meta-analysis). Moreover, practicing
mindfulness may have an impact on the regulation of
attention. This could happen through meditation exercises
during which meditators repeatedly train to focus their
attention for a prolonged period on specific aspects such as
breathing (sustained attention). When they notice that their
mind is wandering (monitoring faculties), they observe this
happening without elaborating the encountered content
(inhibition capacities) and bring their attention back to their
focus point (shifting abilities). In a recent literature review,
Chiesa et al. (2011) showed that better attentional perfor-
mances are observed in people with extensive experience
of mindfulness practice (e.g. experienced Buddhist medi-
tation practitioners) and that practicing mindfulness med-
itation entails significant long-term benefits for most
attentional aspects (sustained, selective and executive
attention).
Only few behavioural studies explored the longitudinal
impact of mindfulness training (e.g. mindfulness retreat,
Mindfulness-Based Stress Reduction program – MBSR) on
cognitive functioning and results are mixed. For example,
Chambers et al. (2008) showed a significant increase in
sustained attention for participants in a 10-day retreat
compared to controls, whereas Anderson et al. (2007) did
not evidence attentional changes (sustained, selective
attention or shifting abilities) in participants in a 8-week
MBSR program compared to controls. Recently, several
neuroscientific studies showed that mindfulness training
causes structural and functional changes in brain structures
that could be related to attentional processing (e.g. anterior
cingulate cortex) (see Ho¨lzel et al. 2011 for a review).
Regarding the acute phase of depression, it has often
been reported that patients present a wide range of cogni-
tive dysfunctions in domains such as attention, memory
and executive functions. More specifically in relation to the
aspects explored in the present article, literature consis-
tently demonstrates that depressed patients show overgen-
eral autobiographical memories recall deficit (see Williams
et al. 2007 for a review), impaired shifting abilities (Mur-
phy et al. 1999), elevated dysfunctional attitudes which are
rigid maladaptive schemes (Beck 1967), and increased
rumination habits that correspond to repeatedly focusing on
symptoms, causes and consequences of sad mood (Nolen-
Hoeksema 1991).
Concerning patients in remission, the literature is less
extensive than for acutely depressed patients and results are
often less unanimous. However, regarding the specific
cognitive functions addressed in the present study, studies
have shown that patients in remission present an over-
general autobiographical memory recall deficit (Williams
et al. 2007). Moreover, it has consistently been shown that
dysfunctional attitudes and ruminative habits could be
cognitive vulnerability factors to relapse in remitted
patients (Segal et al. 2006; Teasdale 1988).
To date, little is known about whether a therapy like
MBCT could impact on cognitive functioning in patients
remitted from depression. Williams et al. (2000) showed
that MBCT participants recalled more specific autobio-
graphical memories after the programme than before,
compared to TAU participants. They postulated that
MBCT may have an impact on autobiographical memory
by training participants to be attentive to specific aspects of
their environment (making encoding more specific may
make retrieval more specific) and encouraging them to
allow mental content to occur without avoiding it (reducing
functional avoidance). MBCT participants also learn to
respond differently to possible rumination episodes, which
may also affect autobiographical memory. Recently, Har-
gus et al. (2010) have explored suicidal depressed patients’
memories and found that at post-assessment, MBCT
patients recalled more specific memories of the warning
signs of their suicidal crises and showed more meta-
awareness (capacity to distinguish the self from the content
of thoughts and emotions) than TAU participants. Alto-
gether, these results seem to indicate that MBCT has an
impact on autobiographical memory. Studies investigating
the influence of MBCT on other cognitive capacities, such
as attention or executive functioning, have been rare.
Recently, Bostanov et al. (2012) showed, with an event-
related brain potential technique, that remitted patients who
took part in MBCT increased their concentration abilities
compared to a waiting list group. In a study examining a
form of mindfulness training derived from MBCT for
healthy participants, Heeren et al. (2009) found no
improvement after MBCT for various tasks measuring
executive functioning (inhibition, flexibility) compared to
non-MBCT participants. Finally, recent studies have shown
that depressive symptomatology decreases over time in
MBCT participants (Godfrin and van Heeringen 2010;
Kuyken et al. 2008; Michalak et al. 2008), whereas
mindfulness capacities increase (Michalak et al. 2008) and
quality of life improves (Godfrin and van Heeringen 2010;
Kuyken et al. 2008).
The general objectives of the present study were two-
fold: determine whether cognitive functioning was actually
altered among patients remitted from depression, in a
cross-sectional perspective, and investigate the possible
impact of MBCT on these functions, in a longitudinal
perspective. More specifically, we hypothesized that
mindfulness meditation would increase a particular aspect
of attention, namely shifting abilities that correspond to the
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capacity to engage and disengage one’s attention. It was
expected that mindfulness practices would lead participants
to be more frequently aware of the present moment in their
daily life. It was postulated that new ways of dealing with
thoughts and emotions would render autobiographical
memories recall less general, and diminish dysfunctional
attitudes and ruminative habits. As participants entering the
MBCT trial were in remission, no effect was expected on
depression severity.
The present study was designed as part of a RCT that
compared the efficacy of MBCT ? TAU and TAU for
relapse prevention in patients remitted from recurrent
depression. Cognitive functions were first measured in
remitted patients at inclusion in the MBCT trial (baseline
measures) and compared with the ones of acutely depres-
sed patients and controls. The impact of MBCT was then
explored in remitted participants who entered the trial and
were assessed again after 3 and 9 months.
Method
Participants
Remitted Participants in the MBCT Trial
Sixty remitted patients (17 men) with at least three past
depressive episodes participated in the MBCT efficacy trial
(Bondolfi et al. 2010). Inclusion criteria were: history of
recurrent major depression according to DSM-IV (Diag-
nostic and Statistical Manual of Mental Disorders; Amer-
ican Psychiatric Association 1994), assessed with the
Structured Clinical Interview for DSM-IV (First et al.
1996); remission at the time of inclusion (Montgomery-
Asberg Depression Rating Scale score B13—MADRS;
Montgomery and Asberg 1979); and off antidepressant
medication. Exclusion criteria were: history of schizo-
phrenia or schizoaffective disorder, current substance
abuse, eating disorder, obsessive compulsive disorder,
organic mental disorder, pervasive developmental disorder,
borderline personality disorder or dysthymia with onset
before age 20. Twenty-nine patients were randomly allo-
cated to TAU and thirty-one patients were allocated to
MBCT plus TAU. The research team was blind to group
assignment.
Study flow chart, as well as detailed information about
power analysis, MBCT program and study procedures have
been provided in our earlier publication (Bondolfi et al.
2010). Briefly, MBCT participants attended 8 weekly 2-h
sessions and TAU participants had unrestricted access to
any type of treatment or help service. Instructors were four
senior CBT psychotherapists all having undergone at least
one training program taught and supervised by one of the
developers of MBCT (Z. Segal). Instructors’ adherence to
the MBCT protocol was evaluated with the MBCT
adherence scale (MBCT-AS; Segal et al. 2002b) and was
shown to be high (see Bondolfi et al. 2010 for more
details). Patient attendance rates were high and MBCT
participants practiced mindfulness exercises regularly (see
Bondolfi et al. 2010 for more details).
Patients were monitored for relapse during the 8-week
intervention and 1-year follow-up. Five participants drop-
ped out during the study (3 patients participated in less than
4 MBCT sessions; 2 patients decided to withdraw after 3
and 5 months, respectively). The occurrence of relapse or
recurrence meeting DSM-IV criteria for major depressive
episode was assessed with the depression module of the
Structured Clinical Interview for DSM-IV (First et al.
1996). Relapse/recurrence was confirmed by a senior psy-
chiatrist listening to the audiotaped assessments. During
the trial, relapse rates were 29 % in the MBCT ? TAU
group (n = 9/31) and 34 % in the TAU group (n = 10/29)
(see Bondolfi et al. 2010 for more details). All participants
who relapsed (n = 19) were excluded from the investiga-
tion because relapse would have been a confounder when
investigating change in cognitive functioning in relation
with MBCT participation. On the one hand, time to relapse
differed in the MBCT ? TAU and TAU groups (see
Bondolfi et al. 2010). On the other hand, re-occurrence of a
depressive episode was expected to directly influence
cognitive measures. The final sample thus included 36
remitted patients (n = 18 MBCT ? TAU, 6 men; n = 18
TAU, 5 men; mean number of past episodes was 4.5, SD
2.2). See remitted sample characteristics in Table 1. Mean
age in the MBCT ? TAU group was 45.4 years (SD 11.6)
and mean number of years of education was 15.6 (SD 3.8);
mean age in the TAU group was 48.2 (SD 9.4) and mean
number of years of education was 15.1 (SD 3.0).
Depressed Participants
Twenty acutely depressed patients (5 men) were recruited in
an adult university psychiatric out-patient clinic specialized
in the treatment of depression (Depression Program). All
patients were diagnosed by experienced psychiatrists during
routine clinical treatment for major depressive episodes
according to DSM-IV criteria. Exclusion criteria were
bipolar disorder, ongoing substance abuse and/or a neuro-
logical problem that would impair cognitive functioning.
None of the patients were in remission. Mean number of past
episodes was 2.4 (SD 2.2), with less than 3 episodes in 70 %
of the sample. All patients except one were taking antide-
pressant medication at the time of testing (4 with SSRIs
[selective serotonin reuptake inhibitor], 6 with SNRIs
[serotonin-norepinephrine reuptake inhibitor], 3 with TCAs
[tricyclic antidepressant], 1 with a MAOI [monoamine
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oxidase inhibitor], 1 with a combination of NSM [norepi-
nephrine-serotonin modulator] and TCA, 2 with a combi-
nation of NSM and SNRI, 1 with a combination of MAOI and
TCA and 1 with a combination of TCA and mood stabilizer).
Five patients were taking benzodiazepines, 3 patients had
antipsychotic medication (prescribed to reduce anxiety) and
5 patients were on both kinds of drugs.
Never-Depressed Control Participants
Twenty comparison participants (5 men) were recruited in
the same cultural community by word of mouth in order to
match depressed participants in terms of gender, age and
education. They had never previously suffered from clini-
cal depression according to DSM-IV criteria and had no
prior neurological impairment or history of substance
abuse as assessed by a clinical psychologist during an
interview.
Characteristics of patients and controls in the 3 groups
are provided in Table 1. There were no differences for age
(see Table 1) and gender (V2 = 0.29; p = 0.86). Remitted
participants had a significantly longer education than
depressed patients (Fisher’s LSD post hoc test, p \ 0.05),
but there was no difference between remitted and control
participants (p = 0.19) and between depressed and control
participants (p = 0.26). As expected from the study design,
remitted participants had experienced more depressive
episodes than acutely depressed patients (t(54) = 3.4;
p \ 0.01).
Tasks
Plus-Minus (PM—adapted from Jersild 1927 and Spector
and Biederman 1976)
The PM task was used to evaluate shifting abilities. Its
reliability and validity have been demonstrated in clinical
samples (e.g. ecstasy-polydrug users—Montgomery et al.
2005) and non-clinical participants (Miyake et al. 2000).
Participants were given a sheet of paper with three lists of
30 two-digit numbers (numbers 10–99). On the first list,
participants were instructed to add 7 to each number and
write down their answers. On the second list, they were
instructed to subtract 7 from each number. On the third list,
participants had to alternate between adding 7 and sub-
tracting 7. Participants were instructed to complete each
list quickly and accurately. Times for completion were
measured in seconds with a stopwatch and errors were
counted. The cost of shifting was calculated as a percent-
age, i.e. the time needed to complete the alternating list
divided by the mean time needed to complete the addition
and subtraction lists.
Table 1 Cross-sectional comparison of acutely depressed patients, patients remitted from depression and never depressed controls with respect
to age, years of education, cognitive tasks and questionnaires
Depressed (n = 20) Remitted (n = 36) Controls (n = 20) One-way ANOVA
Mean SD Mean SD Mean SD F(2,73) p value
Sample characteristics
Age 46.1 8.3 46.8 10.5 45.9 8.8 0.08 0.93
Years of education 12.6 5.0 15.4 3.4 14.0 3.4 3.5 0.036
Cognitive tasks
Autobiographical memory test (AMT; proportion of memories)
Categoric 0.34 0.23 0.19 0.17 0.17 0.19 5.2 0.007
Specific 0.62 0.22 0.74 0.17 0.76 0.20 3.3 0.042
Plus-minus task (PM)
Shift cost (%) 63.0 58.3 20.1 13.7 30.7 27.4 10.3 \0.001
Questionnaires
MADRS 25.8 4.4 4.6 4.4 0.5 0.8 266.9 \0.001
BDI-II 34.7 12.2 8.4 8.5 2.7 2.7 82.1 \0.001
MAAS 50.8 13.7 66.7 11.2 71.3 9.1 18.5 \0.001
DAS 130.7 40.4 115.6 30.9 98.5 17.1 5.3 0.007
RRQ
Rumination 46.3 5.5 37.6 8.7 30.6 7.4 21.2 \0.001
Reflection 35.9 8.8 44.6 7.9 40.0 8.7 7.3 0.001
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Autobiographical Memory Test (AMT—Williams
and Broadbent 1986)
Each participant was given 12 cue words one at a time: six
cue words were positive (e.g. happy, relaxed) and six cue
words were negative (e.g. hopeless, sad). Three sets of 6
positive and 6 negative words were compiled so that the sets
could be counterbalanced across participants. Each set was
matched for word frequency and level of arousal. For each
cue word, participants were asked to recall a specific auto-
biographical memory, i.e. something that happened once in a
particular place at a particular time and lasted no longer than
24 h. Responses were scored according to the following
categories: a) the memory was categoric (happened more
than once); b) the memory was extended (happened once but
lasted more than 24 h); c) the memory was specific; d) no
memory. The proportions of categoric, extended and specific
memories were computed for responses triggered by positive
and negative cue words. As proportion of extended memo-
ries were low (means \0.08), these were not submitted to
statistical analyses. All memories were audiotaped and
scored by two raters. Inter-rater reliability was good
(kappa = 0.71, based on scoring 720 memories) and raters
resolved discrepancies through discussion.
Questionnaires
Montgomery-Asberg Depression Rating Scale
(MADRS—Montgomery and Asberg 1979)
The MADRS is a widely used clinician rated depression
rating scale. Ten items are rated from 0 to 6. Total score
ranges from 0 to 60 with higher score representing more
severe depressive symptoms. The French version used in
this study was translated by Pellet et al. (1980).
Beck Depression Inventory II (BDI-II—Beck et al. 1996)
The BDI-II is a widely used self-report inventory for
assessing the severity of depressive symptoms. Twenty-one
items are rated on a 4-point Likert scale (range 0–3). Total
score ranges from 0 to 63, with higher score representing
more severe depressive symptoms. The French version
used in this study was developed by the Editions du Centre
de Psychologie Applique´e (Beck et al. 1998) and has
shown strong reliability and validity in both clinical
(depressed) and non-clinical samples.
Mindful Attention Awareness Scale (MAAS—Brown
and Ryan 2003)
The MAAS is a 15-item scale that measures the tendency
to be attentive and aware of present moment experience in
daily life in people who have no specific experience with
mindfulness meditation. Items are rated on a 6-point Likert
scale ranging from 1 (almost always) to 6 (almost never).
Total score ranges from 15 to 90 with higher score repre-
senting more present attention and awareness. The English
version was developed among non-clinical adults. The
French version was validated in a non-clinical adult sample
by Jermann et al. (2009). Internal consistency of the French
MAAS was good (Cronbach’s alpha 0.84).
Dysfunctional Attitude Scale (DAS—Weissman and Beck
1978)
The DAS measures the dysfunctional beliefs that are often
related to depression. Forty items are rated on a 7-point
Likert scale (range 1–7). Total score ranges from 40 to 280
with higher score representing more dysfunctional atti-
tudes. The French version was established by Bouvard
et al. (1994). Internal consistency of the French DAS was
good (Cronbach’s alpha 0.79 for depressed patients and
0.86 for control participants).
Rumination/Reflection Questionnaire (RRQ—Trapnell
and Campbell 1999)
The RRQ measures two aspects: rumination (recurrent
negative thoughts about self, but without reference to
depressed mood) and self-reflection (positive thoughts
about self motivated by intellectual curiosity rather than
distress). Items are rated on a 5-point scale ranging from 1
(strongly disagree) to 5 (strongly agree). Scores range from
12 to 60 for each subscale with higher scores correspond-
ing to higher tendencies for rumination or self-reflection.
The English version was developed in student samples. The
French version was validated by Jermann et al. (2010) in a
sample of young adults. Internal consistency of the French
RRQ was good to excellent (Cronbach’s alpha 0.87 for
rumination and 0.92 for self-reflection).
Procedure
All participants were evaluated with the same tasks and
order of questionnaires. Evaluations started with the
MADRS, followed by the AMT, RRQ, PM, DAS and
MAAS. At the end of the evaluation, participants com-
pleted the BDI-II. Depressed and control participants were
evaluated on a single occasion. Remitted patients who
entered the MBCT trial were evaluated on three occasions:
at baseline (T1), after 3 months (T2, 90 ± 14 days) and
9 months (T3, 278 ± 20 days).
The study protocol and informed consent form received
approval from the ethics committee of the Geneva Uni-
versity Hospitals. All participants signed the consent form
1008 Cogn Ther Res (2013) 37:1004–1014
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before the evaluation started. They received a financial
compensation of CHF 50.- (about 50 USD) for their
participation.
Statistical Analysis
One-way analysis of variance (ANOVA) was used to test
for differences between the 3 groups, without and with
adjustment for education level. Significant differences were
further investigated with Fisher’s LSD post hoc tests.
Change over time was analysed with repeated measures
ANOVA, which considered group (MBCT ? TAU vs.
TAU), time (T1 to T3) and time by group interaction.
Associations between number of past depressive episodes
and outcome variables were tested with the Spearman rank-
order correlation coefficient.
Results
Cross-Sectional Assessment: Remitted versus Acutely
Depressed and Control Participants
Means and standard-deviations (SD) of all cognitive mea-
sures and questionnaires are shown in Table 1.
Severity of Depressive Symptoms and Rumination
As expected, significant differences between groups were
observed for the MADRS, BDI-II and RRQ (Table 1).
Regarding depressive symptomatology, post hoc tests
showed that remitted patients displayed significantly lower
scores than depressed patients (Fisher’s LSD post hoc test,
p \ 0.001 for the MADRS; p \ 0.001 for the BDI-II), but
higher scores than control participants (MADRS,
p \ 0.001; BDI-II, p \ 0.05).
On the rumination subscale of the RRQ, remitted
patients similarly displayed lower scores than acutely
depressed patients (p \ 0.001) but higher scores than
control participants (p \ 0.01). On the reflection subscale,
however, remitted patients displayed higher scores than
depressed patients (p \ 0.001) and control participants
(p = 0.05), with no significant difference between the
latter two groups (p = 0.12).
Mindfulness and Dysfunctional Attitudes
One-way ANOVAs showed significant differences for the
MAAS and DAS (Table 1).
Both remitted patients and control participants displayed
higher scores of mindful attention/awareness in daily life
than acutely depressed patients (Fisher’s LSD post hoc test,
p \ 0.001). No significant difference was observed
between remitted and control participants (p = 0.16).
Regarding dysfunctional attitudes, remitted and depres-
sed patients did not significantly differ (p = 0.09). Both
remitted patients (p = 0.05) and acutely depressed patients
(p \ 0.01) had more dysfunctional attitudes than control
participants.
Cognitive Tasks: Autobiographical Memory and Shifting
Abilities
Groups significantly differed with respect to the AMT
proportions of categoric and specific memories and shift
cost in the Plus-Minus task (Table 1).
Regarding autobiographical memory, both remitted
patients and control participants recalled less categoric
memories (Fisher’s LSD post hoc test, p \ 0.01 and p \
0.01, respectively) but more specific memories (p \ 0.05
and p \ 0.05, respectively) than depressed patients.
Remitted patients did not show a significant autobio-
graphical memory deficit compared with control partici-
pants (categoric memories p = 0.78; specific memories
p = 0.72).
In the PM task, remitted patients (p \ 0.001) and con-
trol participants (p \ 0.01) presented less shift cost than
depressed patients. Executive capacity of shifting was not
significantly impaired in remitted patients, as compared to
control participants (p = 0.27).
Effects of Education and Number of Past Depressive
Episodes
Because groups significantly differed with respect to edu-
cation, statistical analyses were repeated after adjustment
for years of education. All group differences in Table 1
remained statistically significant, except for the AMT
proportion of specific memories (p = 0.11).
As number of past depressive episodes was significantly
higher in remitted participants than in acutely depressed
patients, we explored associations between number of
episodes and MADRS, BDI-II, RRQ, MAAS, DAS, AMT
proportions of categoric and specific memories, and shift
cost in the Plus-Minus task. In either remitted or acutely
depressed patients, no significant correlation was observed.
Longitudinal Assessment During MBCT Trial
and Follow-up
Means and standard-deviations (SD) of all cognitive mea-
sures and questionnaires at baseline, 3 and 9-month follow-
up are shown in Table 2.
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Severity of Depressive Symptoms and Rumination
Regarding the clinician-rated MADRS, ANOVA results
indicated a significant group effect, with higher depression
severity in the MBCT ? TAU than TAU group. No time
effect or time by group interaction was detected (Table 2).
For the self-rated BDI-II, a trend toward higher severity in
the MBCT ? TAU group was also found. Depression
severity decreased significantly over time, but no time by
group interaction was observed (Table 2).
For the RRQ, MBCT ? TAU participants had higher
rumination scores than TAU participants. Both groups
showed fewer rumination and reflection habits over time
(Table 2), with no significant time by group interaction for
rumination, and a trend toward different time courses
according to group for reflection.
Mindfulness and Dysfunctional Attitudes
Regarding attention/awareness of the present moment, a
trend toward a group effect was observed (Table 2), with
MBCT ? TAU participants showing lower MAAS scores
than TAU participants. No significant time or time by
group interaction was detected.
For dysfunctional attitudes, a significant time effect and
time by group interaction were observed, in the absence of
a main group effect (Table 2). Planned comparisons
showed that DAS scores decreased from Time 1 to Time 2
(t(16) = 2.91; p \ 0.05) and from Time 2 to Time 3
(t(16) = 2.59; p \ 0.05) in the MBCT ? TAU group. No
significant change over time occurred in the TAU group.
Groups did not significantly differ with respect to baseline
DAS score (t(33) = 0.99; p = 0.33).
Cognitive Tasks: Autobiographical Memory and Shifting
Abilities
No significant time, group or time by group interaction was
observed for categoric memories, specific memories and
PM task (Table 2).
Discussion
Studies that evaluate cognitive changes following MBCT
and compare performances of remitted, acutely depressed
and control participants have been scarce. The present study
considered cognitive functioning, as examined with tasks
(autobiographical memories, shifting), and questionnaires
(rumination, dysfunctional attitudes, frequency of attention/
awareness), both in cross-sectional and longitudinal per-
spectives. Patients in remission from chronic depression (at
least 3 previous episodes) at inclusion in a MBCT ? TAU
vs. TAU trial displayed cognitive functioning similar to that
of control participants for several aspects, such as autobio-
graphical memories, shifting capacities and mindful atten-
tion/awareness. They differed from controls, however, by
having more dysfunctional attitudes, rumination habits and
depressive symptoms. Compared with acutely depressed
patients, remitted patients had similar levels of dysfunctional
attitudes, although they recalled fewer overgeneral memo-
ries, showed better shifting capacities, displayed fewer
depressive symptoms, fewer rumination habits and more
mindful attention/awareness in daily life. Interestingly, they
scored higher on the reflection subscale, possibly in relation
with a high motivation to enter the trial.
The influence of MBCT was explored over the 2-month
intervention and 9-month follow-up. Whereas a significant
decrease was observed for self-rated symptoms (BDI-II),
depression severity, as measured with the MADRS,
remained stable over time, with scores in the range expected
for remitted patients with 1 or 2 mild symptoms, or without
symptom but still considering that they are not back to their
normal selves (Zimmerman et al. 2004). Shifting abilities
and autobiographical memory did not change over time,
whether in the MBCT ? TAU or TAU groups. There was no
evidence that MBCT had any specific impact on ruminative
habits (RRQ) and attention-awareness to the present moment
(MAAS). This latter result should be interpreted in the light
of ongoing discussions about the validity of instruments used
to assess mindfulness. As mentioned by Grossman (2011),
the MAAS might present limitations in terms of validity and
sensitivity to change, in addition to difficulties in semantic
interpretation of the items and possible response bias related
to experience with mindfulness practice.
Specific change with MBCT was detected on a single
aspect of cognitive functioning, namely dysfunctional atti-
tudes, which were significantly higher in remitted and
acutely depressed patients than in controls. Level of dys-
functional attitudes (DAS) significantly decreased during the
intervention and continued decreasing up to 9 months after
starting the MBCT program. Decreased dysfunctional atti-
tudes and unchanged rumination in the present study are in
contrast with Ramel et al. (2004), who showed reduced
rumination but no change in dysfunctional attitudes after
MBSR. Differences between interventions could account for
discrepant results. MBCT is a program specifically tailored
for previously depressed patients to help them identify
thought contents that are often present in depressive states
(automatic thoughts). MBSR is a more general stress man-
agement intervention that does not explicitly focus on
thoughts associated with depression and might not allow
participants to dis-identify with them. Many studies have
questioned the stability of dysfunctional attitudes during the
course of depression. Most of them showed a state depen-
dence of DAS scores (e.g. Ingram et al. 1998; Zuroff et al.
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1999), but some did not (e.g. Beevers and Miller 2004;
Peselow et al. 1990; Zuroff et al. 1999). To account for
inconsistent results, Zuroff et al. (1999) proposed a state-trait
vulnerability model, in which vulnerable people present a
greater availability of dysfunctional attitudes (traits) that are
more or less accessible depending on the severity of
depressive symptoms (state). The present study suggests that
availability of dysfunctional attitudes might be similar in
remitted and depressed patients, with remitted patients par-
ticularly vulnerable to relapse when low mood triggers these
beliefs and makes them more accessible. MBCT meditation
practices may help people identify such thoughts (avail-
ability) at a very early stage and observe them without
engaging with them (decreased accessibility).
The present study also shed some light on the MBCT
efficacy trial, from which the remitted sample was part
(Bondolfi et al. 2010). Whereas MBCT ? TAU signifi-
cantly delayed the time to relapse compared with TAU
alone, both groups relapsed at similar rates over the 1-year
follow-up. When compared to other studies (Bishop et al.
2004; Godfrin and van Heeringen 2010; Teasdale et al.
2000), socio-demographic characteristics and depressive
history of patients in Bondolfi et al. (2010) were quite
similar. However, none of the three previous efficacy
studies explored cognitive functioning. The hypothesis that
MBCT might be particularly efficient for people presenting
cognitive deficits remains to be addressed.
Limitations and Future Studies
The present investigation presents limitations that should be
acknowledged. Firstly, the remitted sample took part in a
trial that did not show the expected relapse prevention effect
(Bondolfi et al. 2010). It might be argued that probability of
observing cognitive changes was low. However, as instruc-
tors’ adherence to the protocol was elevated, participants’
attendance rate was high and practice of mindfulness exer-
cises was regular (see Bondolfi et al. 2010), MBCT might
nevertheless have had an impact on cognitive functioning.
Statistical power is a second limitation. In the cross-sectional
part of the study, small to moderate differences between
groups might have been undetected because of small sample
size, in particular for acutely depressed patients and control
participants. In the longitudinal part of the study, power to
detect small to moderate changes over time was also limited.
A third limitation is associated with task selection and
sequence. On the one hand, a paper–pencil task like the PM
may not have been sensitive enough to detect changes. In the
future, it will be important to measure change with MBCT on
tasks that are known to be related to mood disorders (e.g.
memory bias toward negative content, affective shifting),
and specifically to depression vulnerability (Mathews and
MacLeod 2005). On the other hand, counterbalancing the
order of tasks and questionnaires might be considered in the
future, in order to control for a possible sequence effect.
Fourthly, it should be noted that no structured diagnostic
interview was used in depressed patients, even though
attending psychiatrists had a long experience with DSM-IV
criteria. Furthermore, comorbidity was not investigated
systematically. It might have led to heterogeneity in patient
samples, and a moderating role of comorbid disorders, e.g.
anxiety, cannot be excluded. Moreover, all but one acutely
depressed patient were taking psychotropic medications at
the time of testing, so that drug effects on cognitive func-
tioning cannot be excluded. Finally, number of depressive
episodes significantly differed in the remitted and acutely
depressed patients and might be a confounding factor when
examining differences between groups. Future studies are
awaited to disentangle the effect of group and depression
chronicity, as some data indicate that a larger number of
depressive episodes might be associated with increasing
impairment of cognitive performances (e.g. Kessing 1998).
Taking into account other possible confounders and mod-
erating factors will be another challenge.
Conclusion
In summary, the present study suggests that MBCT might
have a specific impact on dysfunctional attitudes. Changes
were not only observed immediately after group sessions
but continued up to 9 months, in line with the hypothesis of
MBCT-initiated long-term changes. Because of methodo-
logical limitations, these results nevertheless await repli-
cation and confirmation. At the clinical level, when
conducting MBCT groups, clinicians often observe chan-
ges in patients during the 8-week program and participant
feedback confirms the observed changes. At the research
level, further work is needed to measure these gains and
identify the processes through which they happen.
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